Studies in mice have also shown that in vivo [59] or ex vivo [60] priming of donor ABM cells with TPO can accelerate the reconstitution of platelets and red cells and ameliorate post-transplant thrombocytopenia. This evidence concerns the gene TPO and Thrombocytopenia.